Dr. Yocca is an accomplished R&D executive and scientist with extensive experience leading global biopharmaceutical companies. He has wide-ranging expertise in leading high performance, world-class teams in drug discovery and development whose efforts have resulted in a number of prominent neuroscience products including Buspar®, Serzone® Abilify® and Heltioz®. Frank has held leadership roles at AstraZeneca and Bristol Myers Squibb. He is a recognized scientific leader in the neuroscience community and member of the Institute of Medicine of the National Academy of Science, and a Fellow of the American College of Neuropsychopharmacology. He has 45 referred articles, 96 abstracts and 65 invited presentations. Dr. Yocca holds a B.S. in biochemistry from Manhattan College, as well as an M.S. in pharmacology and a Ph.D. in neuropharmacology from St. John’s University.